Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Syncom

Syncom?uq=kzBhZRuG
1988 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of tailor-made custom synthesis and analytical services. The company's custom synthesis and analytical services include chiral technology and medicinal chemistry products, enabling pharma, diagnostic, fine chemical, electronic and pigment industries to get analytical and custom-made scientific technologies.

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Commercial Services
Primary Office
  • P.O. Box 2253
  • 9704 CE Groningen
  • Netherlands

+31 050 000 0000

Syncom Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Syncom‘s full profile, request access.

Request full access to PitchBook

Syncom Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Syncom‘s full profile, request access.

Request full access to PitchBook

Syncom Executive Team (5)

Name Title Board
Seat
Contact
Info
Ton Vries Ph.D Chief Executive Officer
Robert Hof Ph.D Chief Operating Officer
Wolter ten Hoeve Co-Founder & Principal Scientist
Richard Kellogg Ph.D Co-Founder & Scientific Coordinator
Hans Wynberg Co-Founder